Rivaroxaban Impurity 142 | CAS 869785-51-3 - Request Quote
Rivaroxaban Impurity 142
| SZ CAT No: | SZ-R017217 |
| CAS No | 869785-51-3 |
| Mol.F. | C10H9ClN2O4 |
| Mol.Wt. | 256.6 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rivaroxaban Impurity 142 is chemically 4-(2-Chloro-4-nitrophenyl)morpholin-3-one. Rivaroxaban Impurity 142 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 142 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 869785-51-3
Purchase 869785-51-3
Order 869785-51-3
Enquire 869785-51-3
price of 869785-51-3
869785-51-3 Supplier
869785-51-3 Manufacturer
869785-51-3 Exporter
buy high quality Rivaroxaban Impurity 142
Purchase Rivaroxaban Impurity 142
Rivaroxaban Impurity 142 suppliers
Rivaroxaban Impurity 142 manufacturers
Rivaroxaban Impurity 142 price
Order Rivaroxaban Impurity 142
Enquire Rivaroxaban Impurity 142
Rivaroxaban Impurity 142 cost
Rivaroxaban Impurity 142 Supplier
Rivaroxaban Impurity 142 Distributor
Rivaroxaban Impurity 142 for Method Validation
Rivaroxaban Reference Standard
Rivaroxaban Impurity 142 for ANDA Filing
Rivaroxaban Impurity 142 for Forced Degradation Studies
Rivaroxaban Impurity 142 Identification Standards
Rivaroxaban Impurity 142 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


